Zuellig Pharma China Is $470 Million Target Of Cardinal Health Of U.S.
This article was originally published in PharmAsia News
Executive Summary
China's Zuellig Pharma China, a major drug distributor in the country, is being sold to U.S.-based Cardinal Health for $470 million, $410 million of it in cash